COVID-19 Update:Learn more about how we are protecting our patients, families and staff, as well as other important facts about COVID-19.
Genetics Expert Talks about Trends in Newborn Screening and the Orphan Drug Act
February 05, 2015
As part of an editorial collaboration with Medscape Rare Diseases, Marshall Summar, MD, Chief of the Division of Genetics and Metabolism, interviewed Jess Thoene, one of the founders and pioneers in the field of inborn errors in metabolism in rare diseases about newborn screening and the impact of the Orphan Drug Act.
Read the full article here.